RECURSION PHARMACEUTICALS-A (RXRX) Stock Earnings & Estimates
USA - NASDAQ:RXRX - US75629V1044 - Common Stock
4.14 USD
-0.19 (-4.39%)
4.2192 USD
+0.08 (+1.91%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.84M 291.36% | 44.575M 11.89% | 58.839M 32.00% | 73.063M 24.17% | 88.377M 20.96% | 195.11M 120.77% | 173.71M -10.97% | 252.45M 45.33% | 370.87M 46.91% | 529.69M 42.82% | 774.18M 46.16% | |
| EBITDA YoY % growth | -233.97M -34.19% | -324.458M -38.68% | -442.51M -36.38% | -648.423M -46.53% | -548.126M 15.47% | -462.738M 15.58% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -245.73M -34.45% | -348.86M -41.97% | -479.004M -37.31% | -672.095M -40.31% | -559.416M 16.77% | -400.103M 28.48% | -630.972M -57.70% | -605.37M 4.06% | -561.612M 7.23% | -503.472M 10.35% | -397.188M 21.11% | |
| Operating Margin | -616.79% | -782.64% | -814.09% | -919.88% | -632.99% | -205.07% | -363.23% | -239.80% | -151.43% | -95.05% | -51.30% | |
| EPS YoY % growth | -1.37 -12.87% | -1.57 -14.60% | -1.66 -5.73% | -1.64 1.46% | -1.26 22.99% | -0.94 25.51% | -1.10 -17.39% | -0.96 12.96% | -0.81 15.96% | -0.66 17.72% | -0.48 27.69% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 35.53% | -0.36 27.58% | -0.35 13.76% | -0.32 10.75% | -0.32 7.46% |
| Revenue Q2Q % growth | 26.197M 480.74% | 16.606M 12.62% | 17.136M -10.86% | 23.426M 352.68% | 23.834M -9.02% |
| EBITDA Q2Q % growth | -160.014M -8.65% | -152.13M 11.57% | -156.57M -17.68% | -146.88M -36.03% | -149.022M 6.87% |
| EBIT Q2Q % growth | -120.697M 34.32% | -159.885M 16.45% | -152.736M 13.33% | -145.384M 15.57% | -145.928M -20.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.36 -5.88% | -0.38 | 0.02 | 4.61% |
| Q2 2025 Q2Q % growth | -0.41 -2.50% | -0.36 | -0.05 | -14.85% |
| Q1 2025 Q2Q % growth | -0.50 -28.21% | -0.54 | 0.04 | 6.63% |
| Q4 2024 Q2Q % growth | -0.53 -26.19% | -0.44 | -0.09 | -20.37% |
| Q3 2024 Q2Q % growth | -0.34 20.93% | -0.36 | 0.02 | 4.76% |
| Q2 2024 Q2Q % growth | -0.40 -5.26% | -0.41 | 0.01 | 1.55% |
| Q1 2024 Q2Q % growth | -0.39 -14.71% | -0.43 | 0.04 | 9.68% |
| Q4 2023 Q2Q % growth | -0.42 -35.48% | -0.46 | 0.04 | 8.24% |
| Q3 2023 Q2Q % growth | -0.43 -22.86% | -0.39 | -0.04 | -9.50% |
| Q2 2023 Q2Q % growth | -0.38 | -0.38 | 0.00 | 0.47% |
| Q1 2023 Q2Q % growth | -0.34 -3.03% | -0.35 | 0.01 | 4.21% |
| Q4 2022 Q2Q % growth | -0.31 18.42% | -0.30 | -0.01 | -4.80% |
| Q3 2022 Q2Q % growth | -0.35 -25.00% | -0.39 | 0.04 | 9.10% |
| Q2 2022 Q2Q % growth | -0.38 -22.58% | -0.38 | 0.00 | 0.21% |
| Q1 2022 Q2Q % growth | -0.33 75.19% | 0.10 | -0.43 | -423.53% |
| Q4 2021 Q2Q % growth | -0.38 | -0.31 | -0.07 | -21.48% |
| Q3 2021 Q2Q % growth | -0.28 | -0.29 | 0.01 | 1.96% |
| Q2 2021 Q2Q % growth | -0.31 | -0.24 | -0.07 | -30.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 5.175M -80.16% | 17.323M | -12.148M | -70.13% |
| Q2 2025 Q2Q % growth | 19.223M 33.34% | 15.742M | 3.481M | 22.11% |
| Q1 2025 Q2Q % growth | 14.745M 6.89% | 18.479M | -3.734M | -20.21% |
| Q4 2024 Q2Q % growth | 4.511M -58.58% | 19.424M | -14.913M | -76.78% |
| Q3 2024 Q2Q % growth | 26.082M 147.62% | 30.44M | -4.358M | -14.32% |
| Q2 2024 Q2Q % growth | 14.417M 30.86% | 13.522M | 895K | 6.62% |
| Q1 2024 Q2Q % growth | 13.794M 13.68% | 12.903M | 891K | 6.91% |
| Q4 2023 Q2Q % growth | 10.891M -20.39% | 20.76M | -9.869M | -47.54% |
| Q3 2023 Q2Q % growth | 10.533M -19.96% | 13.127M | -2.594M | -19.76% |
| Q2 2023 Q2Q % growth | 11.017M 43.64% | 12.153M | -1.136M | -9.35% |
| Q1 2023 Q2Q % growth | 12.134M 127.65% | 14.734M | -2.6M | -17.65% |
| Q4 2022 Q2Q % growth | 13.68M 440.71% | 24.48M | -10.8M | -44.12% |
| Q3 2022 Q2Q % growth | 13.16M 420.16% | 7.115M | 6.045M | 84.96% |
| Q2 2022 Q2Q % growth | 7.67M 200.78% | 5.508M | 2.162M | 39.25% |
| Q1 2022 Q2Q % growth | 5.33M 108.20% | 85.629M | -80.299M | -93.78% |
| Q4 2021 Q2Q % growth | 2.53M | 6.188M | -3.658M | -59.11% |
| Q3 2021 Q2Q % growth | 2.53M | 2.754M | -224K | -8.13% |
| Q2 2021 Q2Q % growth | 2.55M 1,242.11% | 2.78M | -230K | -8.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.54% | -20.13% | 0.03% | -9.85% |
| Revenue | 0% | -11.55% | 0% | 3.52% |